Hot Features
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) acro... Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.1 | -3.1746031746 | 3.15 | 3.15 | 2.62 | 21027 | 2.90083805 | CS |
| 4 | -0.03 | -0.974025974026 | 3.08 | 3.45 | 2.62 | 16586 | 2.95100539 | CS |
| 12 | -1.51 | -33.1140350877 | 4.56 | 5.0661 | 2.62 | 16921 | 3.60976713 | CS |
| 26 | -2.1 | -40.7766990291 | 5.15 | 6.8938 | 2.62 | 37108 | 5.06685886 | CS |
| 52 | -7.29 | -70.502901354 | 10.34 | 10.34 | 2.62 | 210153 | 6.64386601 | CS |
| 156 | 2.08 | 214.432989691 | 0.97 | 36 | 0.2914 | 484904 | 3.40941496 | CS |
| 260 | 1.31 | 75.2873563218 | 1.74 | 36 | 0.0846 | 1810106 | 0.84375458 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.